Cholangiocarcinoma is a biliary tumor, which not infrequently complicates primary sclerosing cholangitis. It carries a poor prognosis and, with the exception of carefully selected individuals in research protocols, contraindicates orthotopic liver transplantation. There has been some suggestion that
The perspective of liver transplantation for cholangiocarcinoma
โ Scribed by Sven Jonas; Peter Neuhaus
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 71 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21248
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
C omplications of liver transplantation unfortu- nately occur, and they occur in patients who often have had serious and complex medical problems before transplantation. Metabolic, physiological, and pharmacodynamic changes greatly affect their preoperative, intraoperative, and postoperative care. T
Transplant programs are likely to encounter increasing numbers of patients who return after receiving an organ transplant abroad. These patients will require ongoing medical care to monitor their immunosuppression and to provide treatment when the need arises. Transplant societies have condemned tra
Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node-negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC). However, concern has arisen regarding the pot